(Q33348807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

acute myeloid leukemia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

14

Nobuyuki Hamajima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

15

Masao Seto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Makoto Murata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Masahiro Kami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shigeki Ohtake

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Norio Asou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yoshihisa Kodera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Masao Tomonaga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yasufumi Masaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shuya Kusumoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jin Takeuchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shin Matsuda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Hisamaru Hirai

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

m Seiichi Yorimitsu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Masanori Shimoyama

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ryuzo Ohno

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yasuo Morishima

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shigeo Nakamura

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

482-489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12841387%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02986617

5 November 2019

exact match

0 references

cites work

Minimally differentiated acute leukemia

1 reference

12 December 2020

Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)

1 reference

12 December 2020

Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics.

1 reference

12 December 2020

CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside

1 reference

12 December 2020

Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia

1 reference

12 December 2020

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

1 reference

12 December 2020

Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation

1 reference

12 December 2020

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

1 reference

12 December 2020

Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.

1 reference

12 December 2020

Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line

1 reference

12 December 2020

Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). A report on five cases and review of the literature

1 reference

12 December 2020

Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity

1 reference

12 December 2020

Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.

1 reference

12 December 2020

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

1 reference

12 December 2020

Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes

1 reference

12 December 2020

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

12 December 2020

Acute myeloid leukemia with minimal differentiation. A multiple parameter study

1 reference

12 December 2020

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

12 December 2020

Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

1 reference

12 December 2020

Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal

1 reference

12 December 2020

The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score

1 reference

12 December 2020

T-Cell Lymphoblastic Lymphoma With Eosinophilia Associated With Subsequent Myeloid Malignancy

1 reference

12 December 2020

Acute Myeloblasts Leukemia with Minimal Myeloid Differentiation (FAB AML-M0): A Study of Eleven Cases

1 reference

12 December 2020

Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML.

1 reference

12 December 2020

Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia

1 reference

12 December 2020

Myeloblastoma formation in acute myeloid leukemia

1 reference

12 December 2020

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

1 reference

12 December 2020

Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients

1 reference

12 December 2020

Immunologic classification of leukemia and lymphoma

1 reference

12 December 2020

Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).

1 reference

12 December 2020

CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

1 reference

12 December 2020

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

1 reference

12 December 2020

CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity

1 reference

12 December 2020

Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course

1 reference

12 December 2020

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

1 reference

12 December 2020

Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases

1 reference

12 December 2020

Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56)

1 reference

12 December 2020

Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome

1 reference

12 December 2020

Myeloid/natural killer cell precursor acute leukaemia with minor bcr/abl mRNA transcript

1 reference

12 December 2020

Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases

1 reference

12 December 2020

[Diagnosis and treatment of acute undifferentiated leukemia and AML-MO]

1 reference

12 December 2020

Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).

1 reference

12 December 2020

Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years

1 reference

12 December 2020

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy

1 reference

12 December 2020

Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.

1 reference

12 December 2020

CD56+ NK lymphomas: clinicopathological features and prognosis

1 reference

12 December 2020

Minimally differentiated acute nonlymphocytic leukemia: a distinct entity.

1 reference

12 December 2020

Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy

1 reference

12 December 2020

Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

1 reference

12 December 2020

Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0)

1 reference

12 December 2020